Brief: Mabion And Novavax Terminates Research Cooperation On SARS CoV-2 RS Wuhan Variant

Mabion SA

18/10/2023 16:31

Oct 18 (Reuters) - Mabion SA  MABP.WA :
    * DECIDES TO TERMINE STATEMENT OF WORK 8 WITH NOVAVAX
    * FOLLOWING TERMINATION, BOTH PARTIES DECIDES TO STOP CARRY
OUT
RESEARCH ON SARS COV-2 RS
    * SAID RESEARCH REGARDED WUHAN VARIANT OF SARS COV-2 RS
    * COMPANY STILL TO CARRY OUT RESEARCH ON SARS COV-2 RS
OMICRON
VARIANT
    * NOVAVAX INFORMED ABOUT NO NEED TO CONTINUE RESEARCH ON
WUHAN
VARIANT

Source text for Eikon:  ID:nEM1j3HMQa 
Further company coverage:  MABP.WA   NVAX.O 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; 48 58 769 66 00;))